Bartram Richard 4
4 · Esperion Therapeutics, Inc. · Filed Nov 1, 2021
Insider Transaction Report
Form 4
Bartram Richard
Chief Financial Officer
Transactions
- Award
Common Stock
2021-10-29+18,700→ 43,852 total
Holdings
- 26,500
Stock Option (right to buy)
Exercise: $8.94Exp: 2031-10-29→ Common Stock (26,500 underlying)
Footnotes (2)
- [F1]The awards will vest as follows: 50% shall vest upon CVOT public presentation of results; and 50% shall vest upon obtaining approval for cardiovascular risk reduction into the U.S. label.
- [F2]Consists of 43,852 shares of common stock held, including 1,535 shares acquired in Esperion's Employee Stock Purchase Plan.